Noel Donnelly
Finanzdirektor/CFO bei PEPGEN INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Noel Donnelly
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PEPGEN INC. | Finanzdirektor/CFO | 01.10.2021 | - |
Karriereverlauf von Noel Donnelly
Ehemalige bekannte Positionen von Noel Donnelly
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Finanzdirektor/CFO | 01.07.2019 | 01.10.2021 |
Ausbildung von Noel Donnelly
Babson College | Masters Business Admin |
University of Massachusetts Lowell | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Director of Finance/CFO | 2 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PEPGEN INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Noel Donnelly
- Erfahrung